Results 221 to 230 of about 245,199 (308)

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis. [PDF]

Ther Adv Med Oncol
Zhang X, Zhao W, Wang W, Wu J, Fan M, Ma S, Dong M, Zhu L, Wu X, Feng X, Li X, Li L, Sun Z, Wang X, Fu X, Li Z, Yan J, Chang Y, Yu H, Nan F, Zhou Z, Ding M, Zhang J, Zhang L, Zhang M.   +24 more
europepmc   +1 more source

Methotrexate and Tubal Pregnancies: Direct or Indirect Abortion? [PDF]

, 2000
Clark,, Peter A.
core   +1 more source

Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Categorisation of psoriasis (PsO) disease severity in patients varies, although body surface area (BSA) affected is commonly used (< 3% ‘mild’, 3%–10% ‘moderate’ and > 10% ‘severe’). While moderate‐severe PsO has been well‐studied, more limited information regarding mild‐to‐moderate PsO is available.
Emily Goddard, Aaron Keal, James Hetherington, Sophie Barlow, David Wu, Melany Worbes‐Cerezo, Alexander Litvintchouk   +6 more
wiley   +1 more source

Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER). [PDF]

Jpn J Clin Oncol
Sano Y, Miyazaki K, Yamaguchi M, Taguchi S, Machida R, Kawabata K, Fukuda H, Shimada K, Nagai H, Munakata W, Maruyama D, Japan Clinical Oncology Group Lymphoma Study Group.   +11 more
europepmc   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos, Line Kibsgaard, Trine Bertelsen   +2 more
wiley   +1 more source

Evaluation of serial cardiovascular magnetic resonance monitoring and immunosuppressive therapy in predicting outcomes in systemic sclerosis. [PDF]

RMD Open
Kante A, Mghaeith S, Dunogue B, Berezne A, Revel MP, Comarmond C, Chassagnon G, Mouthon L, Chaigne B.   +8 more
europepmc   +1 more source

Clinical Efficacy and Safety of Topical Roflumilast in Psoriasis: An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Traditional first‐line topical treatments for plaque psoriasis, particularly corticosteroids and vitamin D analogs, frequently have only limited efficacy for long‐term use, and present difficulties with safety and adherence. Objectives In this systematic review and meta‐analysis of randomized controlled trials (RCTs), we assessed ...
Aimal A. Khattak, Ahmed Javed, Ummi Aiman Rahman, Rumaisa Riaz, Zeeshan Imtiaz, Hassan A. Mirza, Farman U. Khan, Muhid Khattak, Fatima Javid, Abdul Moiz Khan, Adeline L. Roy, Bibek Shrestha   +11 more
wiley   +1 more source

Leflunomide for Connective Tissue Diseases: A Narrative Review of Efficacy and Safety. [PDF]

Cureus
Navaneethakrishnan B, Mamadapur M.
europepmc   +1 more source

Categorization of Reasons for Hospitalizations in Patients With Cutaneous T‐Cell Lymphoma

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Cutaneous T‐cell lymphomas (CTCL) can significantly impact patients' quality of life as well as impose a substantial healthcare burden due to their complex management and risk of hospitalization. Objectives This study aimed to identify factors associated with hospital admissions among patients with CTCL and to characterize the ...
Geetha Gowda, Sowmya Ravi, Maxwell Green, Caroline Power, Kendall McDaniel, Erin Boh, Carole Bitar   +6 more
wiley   +1 more source